市場調查報告書
商品編碼
1039551

骨關節炎的幹細胞治療的全球市場 - 市場規模、情形、預測:2022年

Global Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2022

出版日期: | 出版商: QYResearch | 英文 89 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球骨關節炎的幹細胞治療的市場規模,從2020年的1,800萬美元,預計到2027年達到8,400萬美元,2021年∼2027年以25.1%的年複合成長率成長。

市場佔有率,亞太地區是90%,歐洲10%。

本報告提供全球骨關節炎的幹細胞治療市場相關調查分析,各市場區隔的市場分析,收益、預測 (2016年∼2027年) 為焦點之系統性資訊。

目錄

第1章 報告概要

  • 調查範圍
  • 市場分析:各類型
    • 全球骨關節炎的幹細胞治療的市場規模的成長率:各類型
    • 同類
    • 自體
  • 市場:各用途
    • 全球骨關節炎的幹細胞治療的市場佔有率:各用途
    • 原發性骨關節炎
    • 次發性骨關節炎
  • 調查目的
  • 象年

第2章 全球成長趨勢

  • 全球骨關節炎的幹細胞治療市場預測
  • 骨關節炎的幹細胞治療的成長趨勢:各地區
  • 骨關節炎的幹細胞治療的產業動態
    • 骨關節炎的幹細胞治療的市場趨勢
    • 骨關節炎的幹細胞治療的市場促進因素
    • 骨關節炎的幹細胞治療的市場課題
    • 骨關節炎的幹細胞治療的市場阻礙因素

第3章 競爭情形:各主要企業

  • 全球骨關節炎的幹細胞治療的主要企業:各收益
  • 全球骨關節炎的幹細胞治療的市場佔有率:各類型企業 (第一級,第二級,第三級)
  • 象企業 - 排行榜:骨關節炎的幹細胞治療的各收益
  • 全球骨關節炎的幹細胞治療的市場集中度
  • 骨關節炎的幹細胞治療的主要企業的總公司與提供區域
  • 骨關節炎的幹細胞治療的主要企業的產品解決方案與服務
  • 骨關節炎的幹細胞治療市場的進入日
  • M&A,擴張計劃

第4章 骨關節炎的幹細胞治療的明細資料:各類型

  • 全球骨關節炎的幹細胞治療的過去的市場規模:各類型
  • 全球骨關節炎的幹細胞治療的市場規模預測:各類型

第5章 骨關節炎的幹細胞治療的明細資料:各用途

  • 全球骨關節炎的幹細胞治療的過去的市場規模:各用途
  • 全球骨關節炎的幹細胞治療的市場規模預測:各用途

第6章 北美

  • 北美的骨關節炎的幹細胞治療的市場規模
  • 北美的骨關節炎的幹細胞治療的市場規模:各類型
  • 北美的骨關節炎的幹細胞治療的市場規模:各用途
  • 北美的骨關節炎的幹細胞治療的市場規模:各國
    • 美國
    • 加拿大

第7章 歐洲

  • 歐洲的骨關節炎的幹細胞治療的市場規模
  • 歐洲的骨關節炎的幹細胞治療的市場規模:各類型
  • 歐洲的骨關節炎的幹細胞治療的市場規模:各用途
  • 歐洲的骨關節炎的幹細胞治療的市場規模:各國
    • 德國
    • 法國
    • 英國
    • 義大利
    • 俄羅斯
    • 北歐各國

第8章 亞太地區

  • 亞太地區的骨關節炎的幹細胞治療的市場規模
  • 亞太地區的骨關節炎的幹細胞治療的市場規模:各類型
  • 亞太地區的骨關節炎的幹細胞治療的市場規模:各用途
  • 亞太地區的骨關節炎的幹細胞治療的市場規模:各地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲

第9章 南美

  • 南美的骨關節炎的幹細胞治療的市場規模
  • 南美的骨關節炎的幹細胞治療的市場規模:各類型
  • 南美的骨關節炎的幹細胞治療的市場規模:各用途
  • 南美的骨關節炎的幹細胞治療的市場規模:各國
    • 墨西哥
    • 巴西

第10章 中東、非洲

  • 中東、非洲的骨關節炎的幹細胞治療的市場規模
  • 中東、非洲的骨關節炎的幹細胞治療的市場規模:各類型
  • 中東、非洲的骨關節炎的幹細胞治療的市場規模:各用途
  • 中東、非洲的骨關節炎的幹細胞治療的市場規模:各國
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第11章 主要企業簡介

  • Medipost
  • Nature Cell
  • Theracell Advanced Biotechnology
  • Takeda (TiGenix)

第12章 分析師的見解/結論

第13章 附錄

目錄

OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility.

Stem cells are the body's raw materials - cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.

Most stem cells used for the experimental treatment of OA are adult MSCs. Researchers can easily collect them from fat or bone marrow. MSCs are able to turn into cartilage, bone, muscle, tendon, ligaments, or fat, depending on the type of tissue that surrounds them. This is why researchers are studying MSCs in stem cell treatments for OA.

In the global market, the core manufacturers of Stem cell therapy for osteoarthritis include Medipost etc, and the top 1 manufacturer accounts for about 80% of the market share. The market include Asia Pacific and Europe, with a share of 90% and 10%. allogeneic accounted for 90% and autologous accounted for 10%. the product is mainly used in primary osteoarthritis and secondary osteoarthritis fields, with a share of 92% and 8%.

Market Analysis and Insights: Global Stem Cell Therapy for Osteoarthritis Market

The global Stem Cell Therapy for Osteoarthritis market size is projected to reach US$ 84 million by 2027, from US$ 18 million in 2020, at a CAGR of 25.1% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cell Therapy for Osteoarthritis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cell Therapy for Osteoarthritis market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cell Therapy for Osteoarthritis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cell Therapy for Osteoarthritis market.

Global Stem Cell Therapy for Osteoarthritis Scope and Market Size

Stem Cell Therapy for Osteoarthritis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Therapy for Osteoarthritis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

  • Allogeneic
  • Autologous

Segment by Application

  • Primary Osteoarthritis
  • Secondary Osteoarthritis

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

By Company

  • Medipost
  • Nature Cell
  • Theracell Advanced Biotechnology
  • Takeda (TiGenix)

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Allogeneic
    • 1.2.3 Autologous
  • 1.3 Market by Application
    • 1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Primary Osteoarthritis
    • 1.3.3 Secondary Osteoarthritis
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2016-2027)
  • 2.2 Stem Cell Therapy for Osteoarthritis Growth Trends by Regions
    • 2.2.1 Stem Cell Therapy for Osteoarthritis Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Share by Regions (2016-2021)
    • 2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Regions (2022-2027)
  • 2.3 Stem Cell Therapy for Osteoarthritis Industry Dynamic
    • 2.3.1 Stem Cell Therapy for Osteoarthritis Market Trends
    • 2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
    • 2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
    • 2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
    • 3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2016-2021)
    • 3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2016-2021)
  • 3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Stem Cell Therapy for Osteoarthritis Revenue
  • 3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
    • 3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2020
  • 3.5 Stem Cell Therapy for Osteoarthritis Key Players Head office and Area Served
  • 3.6 Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
  • 3.7 Date of Enter into Stem Cell Therapy for Osteoarthritis Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type

  • 4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2016-2021)
  • 4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2022-2027)

5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application

  • 5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2016-2021)
  • 5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
  • 6.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type
    • 6.2.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
    • 6.2.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
    • 6.2.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
  • 6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application
    • 6.3.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
    • 6.3.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
    • 6.3.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
  • 6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 6.4.1 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
    • 6.4.2 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
  • 7.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type
    • 7.2.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
    • 7.2.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
    • 7.2.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
  • 7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application
    • 7.3.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
    • 7.3.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
    • 7.3.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
  • 7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 7.4.1 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
    • 7.4.2 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
  • 8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type
    • 8.2.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application
    • 8.3.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region
    • 8.4.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
  • 9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type
    • 9.2.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
    • 9.2.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
    • 9.2.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
  • 9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application
    • 9.3.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
    • 9.3.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
    • 9.3.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
  • 9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 9.4.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
    • 9.4.2 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2016-2027)
  • 10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type
    • 10.2.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application
    • 10.3.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country
    • 10.4.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Medipost
    • 11.1.1 Medipost Company Details
    • 11.1.2 Medipost Business Overview
    • 11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
    • 11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
    • 11.1.5 Medipost Recent Development
  • 11.2 Nature Cell
    • 11.2.1 Nature Cell Company Details
    • 11.2.2 Nature Cell Business Overview
    • 11.2.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
    • 11.2.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
    • 11.2.5 Nature Cell Recent Development
  • 11.3 Theracell Advanced Biotechnology
    • 11.3.1 Theracell Advanced Biotechnology Company Details
    • 11.3.2 Theracell Advanced Biotechnology Business Overview
    • 11.3.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
    • 11.3.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
    • 11.3.5 Theracell Advanced Biotechnology Recent Development
  • 11.4 Takeda (TiGenix)
    • 11.4.1 Takeda (TiGenix) Company Details
    • 11.4.2 Takeda (TiGenix) Business Overview
    • 11.4.3 Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Introduction
    • 11.4.4 Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
    • 11.4.5 Takeda (TiGenix) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details

List of Tables

List of Tables

  • Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
  • Table 2. Key Players of Allogeneic
  • Table 3. Key Players of Autologous
  • Table 4. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
  • Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
  • Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Regions (2016-2021) & (US$ Million)
  • Table 7. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2016-2021)
  • Table 8. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
  • Table 9. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2022-2027)
  • Table 10. Stem Cell Therapy for Osteoarthritis Market Trends
  • Table 11. Stem Cell Therapy for Osteoarthritis Market Drivers
  • Table 12. Stem Cell Therapy for Osteoarthritis Market Challenges
  • Table 13. Stem Cell Therapy for Osteoarthritis Market Restraints
  • Table 14. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2016-2021) & (US$ Million)
  • Table 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2016-2021)
  • Table 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2020)
  • Table 17. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2020
  • Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2016-2021)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Stem Cell Therapy for Osteoarthritis Product Solution and Service
  • Table 21. Date of Enter into Stem Cell Therapy for Osteoarthritis Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
  • Table 24. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2016-2021)
  • Table 25. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2022-2027) (US$ Million)
  • Table 26. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2022-2027) & (US$ Million)
  • Table 27. Global Stem Cell Therapy for Osteoarthritis Market Size Share by Application (2016-2021) & (US$ Million)
  • Table 28. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2016-2021)
  • Table 29. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2022-2027) (US$ Million)
  • Table 30. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2022-2027) & (US$ Million)
  • Table 31. North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
  • Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
  • Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
  • Table 34. North America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
  • Table 35. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
  • Table 36. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
  • Table 37. Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
  • Table 38. Europe Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
  • Table 39. Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
  • Table 40. Europe Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
  • Table 41. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
  • Table 42. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
  • Table 43. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
  • Table 44. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
  • Table 45. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
  • Table 46. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
  • Table 47. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2016-2021) & (US$ Million)
  • Table 48. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2022-2027) & (US$ Million)
  • Table 49. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
  • Table 50. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
  • Table 51. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
  • Table 52. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
  • Table 53. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
  • Table 54. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
  • Table 55. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2016-2021) (US$ Million)
  • Table 56. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Type (2022-2027) & (US$ Million)
  • Table 57. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2016-2021) (US$ Million)
  • Table 58. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Application (2022-2027) & (US$ Million)
  • Table 59. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2016-2021) & (US$ Million)
  • Table 60. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2022-2027) & (US$ Million)
  • Table 61. Medipost Company Details
  • Table 62. Medipost Business Overview
  • Table 63. Medipost Stem Cell Therapy for Osteoarthritis Product
  • Table 64. Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
  • Table 65. Medipost Recent Development
  • Table 66. Nature Cell Company Details
  • Table 67. Nature Cell Business Overview
  • Table 68. Nature Cell Stem Cell Therapy for Osteoarthritis Product
  • Table 69. Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
  • Table 70. Nature Cell Recent Development
  • Table 71. Theracell Advanced Biotechnology Company Details
  • Table 72. Theracell Advanced Biotechnology Business Overview
  • Table 73. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product
  • Table 74. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
  • Table 75. Theracell Advanced Biotechnology Recent Development
  • Table 76. Takeda (TiGenix) Company Details
  • Table 77. Takeda (TiGenix) Business Overview
  • Table 78. Takeda (TiGenix) Stem Cell Therapy for Osteoarthritis Product
  • Table 79. Takeda (TiGenix) Revenue in Stem Cell Therapy for Osteoarthritis Business (2016-2021) & (US$ Million)
  • Table 80. Takeda (TiGenix) Recent Development
  • Table 81. Research Programs/Design for This Report
  • Table 82. Key Data Information from Secondary Sources
  • Table 83. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2020 VS 2027
  • Figure 2. Allogeneic Features
  • Figure 3. Autologous Features
  • Figure 4. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2020 VS 2027
  • Figure 5. Primary Osteoarthritis Case Studies
  • Figure 6. Secondary Osteoarthritis Case Studies
  • Figure 7. Stem Cell Therapy for Osteoarthritis Report Years Considered
  • Figure 8. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2016-2027
  • Figure 9. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), 2016 VS 2021 VS 2027
  • Figure 10. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions: 2020 VS 2027
  • Figure 11. Global Stem Cell Therapy for Osteoarthritis Market Share by Regions (2022-2027)
  • Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2020
  • Figure 13. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2020
  • Figure 14. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2020
  • Figure 15. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2016-2021)
  • Figure 16. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2022-2027)
  • Figure 17. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 18. North America Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
  • Figure 19. North America Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
  • Figure 20. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
  • Figure 21. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 22. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 23. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 24. Europe Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
  • Figure 25. Europe Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
  • Figure 26. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
  • Figure 27. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 28. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 29. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 30. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 31. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 32. Nordic Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 33. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 34. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
  • Figure 35. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
  • Figure 36. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2016-2027)
  • Figure 37. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 38. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 39. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 40. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 41. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 42. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 43. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 44. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
  • Figure 45. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
  • Figure 46. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
  • Figure 47. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 48. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 49. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 50. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Type (2016-2027)
  • Figure 51. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Application (2016-2027)
  • Figure 52. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2016-2027)
  • Figure 53. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 54. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 55. UAE Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2016-2027) & (US$ Million)
  • Figure 56. Medipost Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
  • Figure 57. Nature Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
  • Figure 58. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
  • Figure 59. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2016-2021)
  • Figure 60. Bottom-up and Top-down Approaches for This Report
  • Figure 61. Data Triangulation
  • Figure 62. Key Executives Interviewed